Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07470125
PHASE1
Bioequivalence (BE) Study Between YHP2511 and YHP2511A in Healthy Volunteers
Sponsor: Yuhan Corporation
View on ClinicalTrials.gov
Summary
A randomized, open-label, single-dose, 2-sequence, 2-period, crossover clinical trial to investigate the bioequivalence between YHP2511 and YHP2511A in healthy volunteers
Official title: An Open-label, Randomized, Fasting, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Bioequivalence of YHP2511 With YHP2511A in Healthy Adult Volunteers
Key Details
Gender
All
Age Range
19 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-06-23
Completion Date
2026-07-11
Last Updated
2026-03-13
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
YHP2511
Test drug: YHP2511, Comparator: YHP2511A
DRUG
YHP2511A
Test drug: YHP2511, Comparator: YHP2511A
Locations (1)
H Plus Yangji Hospital
Seoul, South Korea